AMGEN 2041AMGEN 2041AMGEN 2041

AMGEN 2041

No trades
See on Supercharts

Key terms


Outstanding amount
‪600.00 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
4.95% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
5.47%
Maturity date
Oct 1, 2041
Term to maturity
16 years

About AMGEN 2041


Sector
Health Technology
Industry
Biotechnology
Home page
Issue date
Sep 16, 2010
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.